The Resilience Project
The Resilience Project is a project, undertaken by the Icahn School of Medicine at Mount Sinai in collaboration with Sage Bionetworks.[1]
Overview
The project seeks to identify protective factors against disease through collaboration with people who have significant risk factors for disease that nevertheless do not manifest typical signs and symptoms. In a pilot study, big data was used to identify individuals with apparent resistance to severe genetic disease.[2][3][4]
This approach may seem weird, since the gene that is known to cause a genetic disorder could also be dealt with (head on) by just using overwriting the genetic code of this faulty gene with "good code" using gene therapy.
However, there is never just one version of "good code" (even people that do not have a disorder, the gene that is otherwise known to cause the defect can be present with different code). So rather than having to deal with these problems, Stephen Friend decided to use a workaround method (which consists of the approach noted above).[5]
Diseases
Initially, the diseases the project looked at were 170 severe, Mendelian, disorders.[6] However, the genetic data gathered from 600,000 people was not enough[7][a](only resilient individuals of 8 of the targeted diseases were found). The list of diseases it know look at is the following:[8]
- Cystic fibrosis
- Smith–Lemli–Opitz syndrome
- Familial dysautonomia
- Epidermolysis Bullosa simplex
- Pfeiffer syndrome
- Autoimmune polyendocrine syndrome type 1 (APECED)
- Acampomelic campomelic dysplasia
- Atelosteogenesis
Data
DNA sequences from 589,306 people were used, obtained from
Criticism
Critics have argued that the researchers could not contact any of people to positively ensure that they were indeed healthy, despite having the disease mutation. Human geneticist Daniel MacArthur of the Broad Institute in Cambridge, Massachusetts still regards the study as “important as a proof-of-principle”.[9][10]
In response to this criticism, Friend and Schadt have modified their Resilience Project by inviting new volunteers who agree to be recontacted to participate through a website[10]
Participatory Study
In April 2020, the Resilience Project launched a participatory research study open to individuals in the USA.
Similar projects
Notes
- ^ These 600,000 people were not people known to have one of the 170 diseases mentioned. Rather they were everyday people that in some cases carried a gene known to cause a disease, but didn't know they carried it themselves.
References
- ^ "The Resilience Project". resilienceproject.com. Retrieved 14 April 2020.
- ^ "Genetic superheroes". The Economist. 16 April 2016. Retrieved 21 August 2017.
- ^ "Analysis of nearly 600,000 genomes for resilience project". Retrieved 21 August 2017.
- ^ "The Search for Genes That Prevent Disease - Icahn School of Medicine at Mount Sinai". Icahn School of Medicine at Mount Sinai. Retrieved 21 August 2017.
- ^ "Do 'genetic superheroes' exist? Or did media overhype Resilience Project?". 19 April 2016. Retrieved 21 August 2017.
- ^ a b Warren, Mark (19 October 2016). "The Cure for Cancer Is Data—Mountains of Data". Wired. Retrieved 21 August 2017.
- ^ "Search of over 500,000 genomes yields thirteen individuals apparently resistant to severe genetic diseases - GENeS". 11 April 2016. Retrieved 21 August 2017.
- PMID 27065010.
- PMID 26957571.
- ^ a b "'Buffer genes' may protect these 13 people from rare genetic diseases". 11 April 2016. Retrieved 21 August 2017.
- ^ "Mount Sinai Launches App and First Campaign of The Resilience Project to Develop New Treatments and Preventive Care for Diseases". Icahn School of Medicine at Mount Sinai. Retrieved 14 April 2020.